SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019.

Corkery, JM; Hung, W-C; Claridge, H; Goodair, C; Copeland, CS; Schifano, F (2021) Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997-2019. J Psychopharmacol, 35 (11). pp. 1324-1348. ISSN 1461-7285 https://doi.org/10.1177/02698811211021588
SGUL Authors: Goodair, Christine M

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (513kB) | Preview

Abstract

BACKGROUND: Ketamine is a phencyclidine derivative with dissociative anaesthetic properties. Increasing numbers of individuals in England take ketamine recreationally. Information on deaths arising from such use in England is presented. METHODS: Cases were extracted on 31 January 2020 from the National Programme on Substance Abuse Deaths database, based on text searches of the cause of death, coroner's verdict and positive toxicology results for the terms 'ketamine' or 'norketamine'. FINDINGS: During 1997-2005, there were <5 deaths p.a. in which ketamine was implicated. Numbers increased until 2009 (21), plateauing until 2016; thereafter, deaths have risen to about 30 p.a. Decedents' characteristics (N = 283): male 84.1%, mean age 31.2 (SD 10.0) years, employed 56.5%, drug use history 79.6% and living with others 60.3%. Ketamine was detected with other substances in most cases. Main (74.6%) underlying cause of death was accidental poisoning. Ketamine may have impaired judgement in other cases. CONCLUSIONS: Although controlled, recreational ketamine use and related fatalities continue to increase. Consumers need to be more aware of the potentially fatal risks they face.

Item Type: Article
Additional Information: © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: Deaths, England, drug misuse, ketamine, recreational use, Psychiatry, 11 Medical and Health Sciences, 17 Psychology and Cognitive Sciences
SGUL Research Institute / Research Centre: Academic Structure > Population Health Research Institute (INPH)
Journal or Publication Title: J Psychopharmacol
ISSN: 1461-7285
Language: eng
Dates:
DateEvent
1 November 2021Published
5 June 2021Published Online
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
NPSAD 2004–2019Public Health Englandhttp://dx.doi.org/10.13039/501100002141
PubMed ID: 34092131
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113348
Publisher's version: https://doi.org/10.1177/02698811211021588

Actions (login required)

Edit Item Edit Item